STANFORD UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-11-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.stanford.edu
A Novel Noninvasive Thermoregulatory Device for Postural Tachycardia Syndrome
Not Applicable
Completed
- Conditions
- Postural Tachycardia Syndrome
- Interventions
- Device: Embr Device
- First Posted Date
- 2021-06-29
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 23
- Registration Number
- NCT04943276
- Locations
- 🇺🇸
Stanford Neuroscience Health Center, Stanford, California, United States
Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults with Neurofibromatosis Type 1
Recruiting
- Conditions
- Neurofibromatosis 1
- First Posted Date
- 2021-06-28
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 1000
- Registration Number
- NCT04941027
- Locations
- 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, California, United States
🇺🇸Stanford University, Redwood City, California, United States
Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease
Terminated
- Conditions
- CirrhosisHepatic Encephalopathy
- Interventions
- Device: Neurofit (oculometric testing)
- First Posted Date
- 2021-06-25
- Last Posted Date
- 2021-06-25
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 48
- Registration Number
- NCT04940416
- Locations
- 🇺🇸
Stanford University School of Medicine, Redwood City, California, United States
Outreach and Choice in Colorectal Cancer Screening
Not Applicable
- Conditions
- Colorectal Cancer Screening
- Interventions
- Behavioral: Outreach
- First Posted Date
- 2021-06-25
- Last Posted Date
- 2021-09-27
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 5000
- Registration Number
- NCT04940442
- Locations
- 🇺🇸
Stanford University Primary Care Clinics, Palo Alto, California, United States
Eye Movement Testing in Patients With Obesity and the Impact of Weight Loss Surgery
Terminated
- Conditions
- Bariatric Surgery CandidateObesity, Morbid
- Interventions
- Device: NeurofitDiagnostic Test: Psychometric hepatic encephalopathy score
- First Posted Date
- 2021-06-25
- Last Posted Date
- 2021-06-25
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 19
- Registration Number
- NCT04940429
- Locations
- 🇺🇸
Stanford University School of Medicine, Redwood City, California, United States
Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
Phase 2
Recruiting
- Conditions
- Craniofacial PainMigraineTrigeminal Autonomic CephalgiaParoxysmal HemicraniaCluster HeadacheSphenopalatine Ganglion Neuralgia
- Interventions
- Drug: Exparel (Bupivacaine Liposome)Drug: Saline
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 15
- Registration Number
- NCT04930887
- Locations
- 🇺🇸
Peter H Hwang, Stanford, California, United States
The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis
Phase 1
Recruiting
- Conditions
- Osteoarthritis ShoulderShoulder Pain
- Interventions
- Biological: Micro Fragmented Adipose TissueBiological: Corticosteroid injection
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 48
- Registration Number
- NCT04929951
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
Risk Factors for Long-term Opioid Use
Completed
- Conditions
- Pain Syndrome
- Interventions
- Other: No intervention - retrospective observational cohort study
- First Posted Date
- 2021-06-16
- Last Posted Date
- 2022-04-14
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 1500392
- Registration Number
- NCT04928131
Examining the Effectiveness of Deep TMS in Veterans With Alcohol Use Disorder
Not Applicable
Active, not recruiting
- Conditions
- Alcohol Use Disorder (AUD)Transcranial Magnetic Stimulation
- Interventions
- Device: Deep Transcranial Magnetic Stimulation (dTMS) H7 coil
- First Posted Date
- 2021-06-16
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 8
- Registration Number
- NCT04927364
- Locations
- 🇺🇸
VA Palo Alto Health Care System, Palo Alto, California, United States
Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies
Phase 2
Recruiting
- Conditions
- Nasopharyngeal CancerEpstein-Barr Virus Related Carcinoma
- Interventions
- Drug: VK-2019
- First Posted Date
- 2021-06-14
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 61
- Registration Number
- NCT04925544
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
© Copyright 2025. All Rights Reserved by MedPath